Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients

Parag Mahale; Eric A Engels; Charles F Lynch; Lindsay M Morton

doi:10.1111/bjh.15828

Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients

Br J Haematol. 2019 Jul;186(2):347-351. doi: 10.1111/bjh.15828. Epub 2019 Feb 28.

Authors

Parag Mahale¹, Eric A Engels¹, Charles F Lynch², Lindsay M Morton³

Affiliations

¹ Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Department of Epidemiology, The University of Iowa College of Public Health, Iowa City, IA, USA.
³ Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Keywords: lymphoid malignancies; non-Hodgkin lymphoma; post-transplant lymphoproliferative disorders; second primary cancers; solid organ transplant recipients.

Publication types

Letter
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adolescent
Adult
Aged
Child
Child, Preschool
Female
Humans
Infant
Infant, Newborn
Lymphoproliferative Disorders / etiology
Lymphoproliferative Disorders / therapy*
Male
Middle Aged
Neoplasms / etiology*
Organ Transplantation / adverse effects*
Postoperative Complications / etiology
Risk Factors
Transplant Recipients / statistics & numerical data
Young Adult

Publication types

MeSH terms

Grants and funding